MLM Biologics Developing Wound Infection Prevention Device for Military

The U.S. Army Medical Research and Development Command (USAMRDC) recently awarded UF Innovate | Accelerate’s Sid Martin Biotech alum MLM Biologics Inc. nearly $1.5 million to develop a device to prevent infection in battlefield wounds. The product will incorporate MLM Biologic’s proprietary collagen processing and stabilization technologies.

MLM Biologics competed for the award in the battlefield treatment area, focused on preventing infection in wounds from “…complex, traumatic, penetrating injuries in a far-forward, austere environment.”

“We’re honored to bring our solutions to the men and women who stand in harm’s way as our focus has always been on wound closure—not just wound management,” CEO Chandra Nataraj stated.

As part of the award, MLM Biologics will develop a new medical device using its proprietary technologies combined with proven anti-inflammatory and anti-microbial components, Nataraj said. He believes it will eventually be available for civilian clinical use.

Learn more about MLM Biologics Developing Wound Infection Prevention Device for Military